- Home
- PROK vs FSBW Comparison
PROK vs FSBW Comparison
Compare PROK & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FSBW
- Stock Information
- Founded
- PROK 2015
- FSBW 1936
- Country
- PROK United States
- FSBW United States
- Employees
- PROK N/A
- FSBW N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FSBW Banks
- Sector
- PROK Health Care
- FSBW Finance
- Exchange
- PROK Nasdaq
- FSBW Nasdaq
- Market Cap
- PROK 334.8M
- FSBW 322.3M
- IPO Year
- PROK N/A
- FSBW 2012
- Fundamental
- Price
- PROK $2.45
- FSBW $41.56
- Analyst Decision
- PROK Buy
- FSBW Hold
- Analyst Count
- PROK 5
- FSBW 1
- Target Price
- PROK $6.25
- FSBW $44.00
- AVG Volume (30 Days)
- PROK 2.4M
- FSBW 16.5K
- Earning Date
- PROK 11-11-2025
- FSBW 10-21-2025
- Dividend Yield
- PROK N/A
- FSBW 2.70%
- EPS Growth
- PROK N/A
- FSBW N/A
- EPS
- PROK N/A
- FSBW 4.15
- Revenue
- PROK $527,000.00
- FSBW $139,676,000.00
- Revenue This Year
- PROK $265.05
- FSBW $9.62
- Revenue Next Year
- PROK N/A
- FSBW $5.35
- P/E Ratio
- PROK N/A
- FSBW $9.98
- Revenue Growth
- PROK N/A
- FSBW 0.61
- 52 Week Low
- PROK $0.46
- FSBW $34.61
- 52 Week High
- PROK $7.13
- FSBW $49.15
- Technical
- Relative Strength Index (RSI)
- PROK 50.33
- FSBW 51.13
- Support Level
- PROK $2.12
- FSBW $41.20
- Resistance Level
- PROK $3.05
- FSBW $42.23
- Average True Range (ATR)
- PROK 0.23
- FSBW 0.68
- MACD
- PROK 0.03
- FSBW -0.11
- Stochastic Oscillator
- PROK 35.48
- FSBW 22.83
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FSBW FS Bancorp Inc.
FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.